Evogene (EVGN) Prepaid Assets (2016 - 2018)
Evogene (EVGN) posted Prepaid Assets of $275000.0 for Q4 2018, up 23.32% sequentially from $223000.0 in Q4 2017, and up 23.32% YoY from $223000.0 in Q4 2017.
Evogene (EVGN) Prepaid Assets (2016 - 2018) Analysis & Trends
Evogene has reported Prepaid Assets for 3 years, with the latest figure at $275000.0 in Q4 2018.
- Quarterly Prepaid Assets rose 23.32% year-over-year to $275000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $275000.0 (up 23.32% YoY) and the FY2018 annual result came in at $275000.0, up 23.32% from the prior year.
- Prepaid Assets grew to $275000.0 in Q4 2018 per EVGN's latest filing, from $223000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $275000.0 in Q4 2018 and troughed at $157000.0 in Q4 2016.
- A 3-year average of $218333.3 and a median of $223000.0 in 2017 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2017 and 2018: Prepaid Assets jumped 42.04% in 2017, then advanced 23.32% in 2018.
- Over 3 years, Prepaid Assets stood at $157000.0 in 2016, then soared by 42.04% to $223000.0 in 2017, then rose by 23.32% to $275000.0 in 2018.
- According to Business Quant data, Prepaid Assets over the past three periods registered $275000.0, $223000.0, and $157000.0 for Q4 2018, Q4 2017, and Q4 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 275,000.00 |
| Dec 31, 2017 | 223,000.00 |
| Dec 31, 2016 | 157,000.00 |